Rabeprazole with LevosulpirideREVAGO L CAPSULE

Revago L is a dual action fixed dose combination of rabeprazole, a proton pump inhibitor and Levosulpiride, a prokonetic, used primarily to manage disorders related to excess stomach acid and delayed gastric emptying.

• Dosage: Once Daily OR as directed by the Physician
• Form: Capsule
• Indications:
  1. Gastroesophageal Reflux Disease with Gastroparesis
  2. Functional dyspepsia
  3. Peptic ulcer disease
  4. Chronic gastritis
  5. Nausea and vomiting associated with acid reflux
  6. Non-ulcer dyspepsia and post-meal fullness
• Composition: Rabeprazole 20 mg + Levosulpiride 75mg
• Mode of Action: Revago L works through a dual mechanism by suppressing gastric acid secretion and enhancing upper GI motility, thereby improving symptoms associated with acid-peptic disorders and delayed gastric emptying.
• Packaging:10*1*10’S
• Therapy Area: Gastroenterology